Literature DB >> 26832688

Generation of Genetically Modified Mice Using the CRISPR-Cas9 Genome-Editing System.

Jorge Henao-Mejia1, Adam Williams2, Anthony Rongvaux3, Judith Stein3, Cynthia Hughes3, Richard A Flavell3,4.   

Abstract

Genetically modified mice are extremely valuable tools for studying gene function and human diseases. Although the generation of mice with specific genetic modifications through traditional methods using homologous recombination in embryonic stem cells has been invaluable in the last two decades, it is an extremely costly, time-consuming, and, in some cases, uncertain technology. The recently described CRISPR-Cas9 genome-editing technology significantly reduces the time and the cost that are required to generate genetically engineered mice, allowing scientists to test more precise and bold hypotheses in vivo. Using this revolutionary methodology we have generated more than 100 novel genetically engineered mouse strains. In the current protocol, we describe in detail the optimal conditions to generate mice carrying point mutations, chromosomal deletions, conditional alleles, fusion tags, or endogenous reporters.
© 2016 Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Year:  2016        PMID: 26832688      PMCID: PMC4905559          DOI: 10.1101/pdb.prot090704

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  1 in total

1.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

  1 in total
  33 in total

1.  The long noncoding RNA Morrbid regulates CD8 T cells in response to viral infection.

Authors:  Jonathan J Kotzin; Fany Iseka; Jasmine Wright; Megha G Basavappa; Megan L Clark; Mohammed-Alkhatim Ali; Mohamed S Abdel-Hakeem; Tanner F Robertson; Walter K Mowel; Leonel Joannas; Vanessa D Neal; Sean P Spencer; Camille M Syrett; Montserrat C Anguera; Adam Williams; E John Wherry; Jorge Henao-Mejia
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

Review 2.  What rheumatologists need to know about CRISPR/Cas9.

Authors:  Gary J Gibson; Maozhou Yang
Journal:  Nat Rev Rheumatol       Date:  2017-02-09       Impact factor: 20.543

3.  Group 1 Innate Lymphoid Cell Lineage Identity Is Determined by a cis-Regulatory Element Marked by a Long Non-coding RNA.

Authors:  Walter K Mowel; Sam J McCright; Jonathan J Kotzin; Magalie A Collet; Asli Uyar; Xin Chen; Alexandra DeLaney; Sean P Spencer; Anthony T Virtue; EnJun Yang; Alejandro Villarino; Makoto Kurachi; Margaret C Dunagin; Gretchen Harms Pritchard; Judith Stein; Cynthia Hughes; Diogo Fonseca-Pereira; Henrique Veiga-Fernandes; Arjun Raj; Taku Kambayashi; Igor E Brodsky; John J O'Shea; E John Wherry; Loyal A Goff; John L Rinn; Adam Williams; Richard A Flavell; Jorge Henao-Mejia
Journal:  Immunity       Date:  2017-09-19       Impact factor: 31.745

4.  Overview of CRISPR-Cas9 Biology.

Authors:  Hannah K Ratner; Timothy R Sampson; David S Weiss
Journal:  Cold Spring Harb Protoc       Date:  2016-12-01

5.  The secreted protein DEL-1 activates a β3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration.

Authors:  Da-Yo Yuh; Tomoki Maekawa; Xiaofei Li; Tetsuhiro Kajikawa; Khalil Bdeir; Triantafyllos Chavakis; George Hajishengallis
Journal:  J Biol Chem       Date:  2020-04-12       Impact factor: 5.157

6.  GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.

Authors:  Xi Chen; Shuchi Gupta; Matthew Cooper; Daniel DeHelian; Xuefei Zhao; Meghna U Naik; Jeremy G T Wurtzel; Timothy J Stalker; Lawrence E Goldfinger; Jeffrey Benovic; Lawrence F Brass; Steven E McKenzie; Ulhas P Naik; Peisong Ma
Journal:  Blood Adv       Date:  2020-01-14

7.  CALHM3 Is Essential for Rapid Ion Channel-Mediated Purinergic Neurotransmission of GPCR-Mediated Tastes.

Authors:  Zhongming Ma; Akiyuki Taruno; Makoto Ohmoto; Masafumi Jyotaki; Jason C Lim; Hiroaki Miyazaki; Naomi Niisato; Yoshinori Marunaka; Robert J Lee; Henry Hoff; Riley Payne; Angelo Demuro; Ian Parker; Claire H Mitchell; Jorge Henao-Mejia; Jessica E Tanis; Ichiro Matsumoto; Michael G Tordoff; J Kevin Foskett
Journal:  Neuron       Date:  2018-04-19       Impact factor: 17.173

8.  Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion.

Authors:  Ruth Choa; Junichiro Tohyama; Shogo Wada; Hu Meng; Jian Hu; Mariko Okumura; Rebecca M May; Tanner F Robertson; Ruth-Anne Langan Pai; Arben Nace; Christian Hopkins; Elizabeth A Jacobsen; Malay Haldar; Garret A FitzGerald; Edward M Behrens; Andy J Minn; Patrick Seale; George Cotsarelis; Brian Kim; John T Seykora; Mingyao Li; Zoltan Arany; Taku Kambayashi
Journal:  Science       Date:  2021-07-30       Impact factor: 47.728

9.  Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.

Authors:  Nabil F Darwich; Jessica M Phan; Boram Kim; EunRan Suh; John D Papatriantafyllou; Lakshmi Changolkar; Aivi T Nguyen; Caroline M O'Rourke; Zhuohao He; Sílvia Porta; Garrett S Gibbons; Kelvin C Luk; Sokratis G Papageorgiou; Murray Grossman; Lauren Massimo; David J Irwin; Corey T McMillan; Ilya M Nasrallah; Camilo Toro; Geoffrey K Aguirre; Vivianna M Van Deerlin; Edward B Lee
Journal:  Science       Date:  2020-10-01       Impact factor: 47.728

10.  m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.

Authors:  Jing Zhou; Xingli Zhang; Jiajia Hu; Rihao Qu; Zhibin Yu; Hao Xu; Huifang Chen; Lichong Yan; Chenbo Ding; Qiang Zou; Youqiong Ye; Zhengting Wang; Richard A Flavell; Hua-Bing Li
Journal:  Sci Adv       Date:  2021-06-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.